Study identifies new genetic signatures of breast cancer drug resistance
Monday, January 10, 2011 - 16:32
in Health & Medicine
A new study conducted by Josh LaBaer's research team in the Biodesign Institute at Arizona State University has pinpointed more than 30 breast cancer gene targets -- including several novel genes -- that are involved in drug resistance to a leading chemotherapy treatment.